Menière’s disease (MD) is a chronic disease with a reported prevalence of 17–513 patients per 100,000 . It is characterized by spontaneous episodic attacks of vertigo, fluctuating low-frequency hearing loss, tinnitus, and aural fullness [1, 2]. More than 150 years ago, Prosper Menière was the first to recognize the inner ear as the site of origin for this disease . Hallpike pointed out the endolymphatic hydrops (EH) as the pathological counterpart for MD . EH is indeed a condition characterized by a distension of the structures filled with endolymph. The cochlear duct, the saccule, the utricle or ampullae contain endolymph. A change in volume of these structures has been proven to correlate with the symptoms of MD .
Recent developments of high-resolution MR imaging of the inner ear have now enabled us to visualize in vivo EH in patients with suspected MD.
The data on the use of non-contrast MR techniques in the evaluation of patients with MD in literature are limited. So far, only two papers have documented the saccule measurement on coronal reformations of a heavily T2- weighted sequence [6, 7]. On these images, the saccule can be detected as a small oval hypo-intense lesion in the vestibule on a coronal reconstruction. Overall, the height of the saccule in patients with MD is reported to be over 1.6 mm. The advantage of this technique is that it requires no contrast administration. The disadvantage is that it only evaluates vestibular hydrops; cochlear hydrops is not evaluated. The reproducibility of measuring such small anatomical structures remains to be confirmed.
The contrast-enhanced hydrops MR imaging essentially exists out of two different contrast techniques, that is intratympanically gadolinium (Gd)-based contrast medium administration and intravenous Gd-based contrast administration with subsequent delayed MR imaging.
In 2007, Nakashima et al reported the clear visualization of EH in patients with MD by an intratympanic injection of a Gd-based contrast medium using a three-dimensional fluid attenuated inversion recovery (3D-FLAIR) sequence on a 3T machine . Intratympanic injection of Gd, however, is considered an off-label use of Gd and moreover, only one ear can be evaluated at a time .
The intravenous (IV) administration of Gd has the advantage of being able to evaluate both ears at the same time. Moreover, it is an approved use of Gd [9, 10]. MRI four hours after a double dose of IV Gd administration gives the maximum peri-lymphatic contrast enhancement of both, symptomatic and asymptomatic, ears [9, 10]. To have the highest SNR ratio and to optimize the image quality, a 3 T magnet is required with a dedicated head and neck coil. In most reports, a 3D-FLAIR sequence is used. The disadvantage is that these sequences are time-consuming, so patient immobilization in order to avoid motion degradation is crucial [9, 10].
Various semi-quantitative grading criteria have been proposed. Baráth et al.  defined the normal situation as a hardly visible non-enhancing cochlear duct in the enhancing scala vestibuli and scala tympani (Figure 1a).
Grade I cochlear hydrops is defined as a mild dilation of the non-enhancing cochlear duct into the scala vestibuli with partial obstruction of the scala vestibuli (Figure 1b).
In grade II cochlear hydrops, the scala vestibuli is uniformly obstructed by the maximally distended cochlear duct (Figure 1c). In the vestibule – in normal cases – one can clearly discriminate the non-enhancing saccule and utricle in the enhancing vestibule. The saccule is the smallest of both structures and is located anterior, inferior, and medial in the vestibule (Figure 2a). A grade I vestibular hydrops presents as a distention of the endolymphatic space of the saccule, utricle, or both, with the enhancing perilymphatic space still visible along the periphery of the bony vestibule (Figure 2c) . In a grade II vestibular hydrops, the saccule and utricle are extremely distended without any visible surrounding enhancing perilymphatic space (Figure 2d). By using this technique and classification, Baráth et al found a high interobserver agreement . Ninety percent of clinically diseased ears had EH on MR imaging, whereas 78% of the clinically normal ears had no EH on MR imaging. However, 22% of clinically normal ears showed EH on MR imaging and 10% of ears with clinical diagnosis of MD did not show EH .
In a more recent study, the semi-quantitative grading system was questioned as the authors noted that saccular abnormalities were much more frequent than those of the utricle on temporal bone sections . They proposed the inversion of the saccule to utricle ratio (SURI) on an oblique sagittal section as a marker of EH. SURI was only found in patients with MD (50%) and was felt to be a more reliable approach than conventional semi-quantitative methods for distinguishing subjects with MD from healthy subjects .
Our own data of a recent study  with delayed Gd-enhanced 3D-FLAIR MR imaging on 148 patients (296 ears) also confirm that adding an extra low-grade vestibular hydrops to the Baráth classification – in which the saccule, normally the smallest of the vestibular sacs, has become equal or larger than the utricle but not yet confluent – raises the sensitivity without loss of specificity for the diagnosis of definite MD (Figure 2b). By adding this extra low-grade vestibular hydrops, the classification for vestibular hydrops goes from a three-stage grading system  to a four-stage grading system resulting in a higher accuracy of MR imaging in detecting MD .
It has already been described that the disruption of the blood-perilymph barrier results in an asymmetrical enhancement of the membranous labyrinth in patients with MD [14, 15]. The enhancement in patients with MD is more pronounced on the affected side [14, 15]. Our study  confirms this asymmetrical perilymphatic enhancement (PE) in patients with MD (Figure 3). Moreover, our data show that adding this PE criterium to the EH criteria augments the specificity while maintaining the sensitivity .
In conclusion, delayed IV Gd-enhanced MR technique is the most frequently used technique and is able to visualize and grade endolymphatic hydrops in patients with definite MD with a high sensitivity and specificity. A four-stage EH grading system in combination with PE assessment gives the best diagnostic accuracy.
The author has no competing interests to declare.
Nakashima, T, Pyykkö, I, Arroll, MA, et al. Menière’s disease. Nat Rev Dis Primers. 2016 May 12; 2: 16028. DOI: https://doi.org/10.1038/nrdp.2016.28
Sajjadi, H and Paparella, MM. Meniere’s disease. Lancet. 2008; 372: 406–14. DOI: https://doi.org/10.1016/S0140-6736(08)61161-7
Salt, AN and Plontke, SK. Endolymphatic hydrops: Pathophysiology and experimental models. Otolaryngol Clin N Am. 2010; 43: 971–983. DOI: https://doi.org/10.1016/j.otc.2010.05.007
Venkatasamy, A, Veillon, F, Fleury, A, et al. Imaging of the saccule for the diagnosis of endolymphatic hydrops in Meniere disease, using a three-dimensional T2-weighted steady state free precession sequence: Accurate, fast, and without contrast material intravenous injection. Eur Radiol Exp. 2017; 1: 14. DOI: https://doi.org/10.1186/s41747-017-0020-7
Simon, F, Guichard, JP, Kania, R, et al. Saccular measurements in routine MRI can predict hydrops in Menière’s disease. Eur Arch Otorhinolaryngol. 2017; 274: 4113–4120. DOI: https://doi.org/10.1007/s00405-017-4756-8
Nakashima, T, Naganawa, S, Sugiura, M, et al. Visualization of endolymphatic hydrops in patients with Menière’s disease. Laryngoscope. 2007; 117: 415–420. DOI: https://doi.org/10.1097/MLG.0b013e31802c300c
Lingam, RK, Connor, SEJ, Casselman, JW and Beale, T. MRI in otology: Applications in cholesteatoma and Ménière’s disease. Clin Radiol. 2018; 73: 35–44. DOI: https://doi.org/10.1016/j.crad.2017.09.002
Naganawa, S and Nakashima, T. Visualization of endolymphatic hydrops with MR imaging in patients with Ménière’s disease and related pathologies: Current status of its methods and clinical significance. Jpn J Radiol. 2014; 32: 191–204. DOI: https://doi.org/10.1007/s11604-014-0290-4
Baráth, K, Schuknecht, B, Naldi, AM, et al. Detection and grading of endolymphatic hydrops in Menière disease using MR imaging. Am J Neuroradiol. 2014; 35: 1387–92. DOI: https://doi.org/10.3174/ajnr.A3856
Attyé, A, Eliezer, M, Boudiaf, N, et al. MRI of endolymphatic hydrops in patients with Menière’s disease: A case-controlled study with a simplified classification based upon saccular morphology. Eur Radiol. 2017; 27: 3138–3146. DOI: https://doi.org/10.1007/s00330-016-4701-z
Pakdaman, MN, Ishiyama, G, Ishiyama, A, et al. Blood-Labyrinth barrier permeability in Menière disease and idiopathic sudden sensorineural hearing loss: Findings on delayed postcontrast 3D-FLAIR MRI. Am J Neuroradiol. 2016; 37: 1903–08. DOI: https://doi.org/10.3174/ajnr.A4822
Ishiyama, G, Lopez, IZ, Ishiyama, P, Vinters, HV and Ishiyama, A. The blood labyrinthine barrier in the human normal and Menière’s disease macula utriculi. Sci Rep. 2017 Mar 21; 7(1): 253. DOI: https://doi.org/10.1038/s41598-017-00330-5